Envista Holdings Corp (NVST)

USD 18.2

(-5.41%)

Net Debt Summary of Envista Holdings Corp

  • Envista Holdings Corp's latest annual net debt in 2023 was 713.6 Million USD , down -22.62% from previous year.
  • Envista Holdings Corp's latest quarterly net debt in 2024 Q3 was 430.1 Million USD , down -3.76% from previous quarter.
  • Envista Holdings Corp reported annual net debt of 922.2 Million USD in 2022, up 138.73% from previous year.
  • Envista Holdings Corp reported annual net debt of 386.3 Million USD in 2021, down -64.62% from previous year.
  • Envista Holdings Corp reported quarterly net debt of 606.5 Million USD for 2024 Q2, down -13.05% from previous quarter.
  • Envista Holdings Corp reported quarterly net debt of 697.5 Million USD for 2024 Q1, down -2.26% from previous quarter.

Annual Net Debt Chart of Envista Holdings Corp (2023 - 2017)

Historical Annual Net Debt of Envista Holdings Corp (2023 - 2017)

Year Net Debt Net Debt Growth
2023 713.6 Million USD -22.62%
2022 922.2 Million USD 138.73%
2021 386.3 Million USD -64.62%
2020 1.09 Billion USD -17.68%
2019 1.32 Billion USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%

Peer Net Debt Comparison of Envista Holdings Corp

Name Net Debt Net Debt Difference
Alcon Inc. 4.04 Billion USD 82.379%
AptarGroup, Inc. 961.03 Million USD 25.746%
Baxter International Inc. 11.16 Billion USD 93.609%
Becton, Dickinson and Company 14.46 Billion USD 95.066%
Bausch + Lomb Corporation 4.23 Billion USD 83.134%
Haemonetics Corporation 695.08 Million USD -2.664%
ResMed Inc. 635.57 Million USD -12.276%
Teleflex Incorporated 1.7 Billion USD 58.11%
Warby Parker Inc. -42.43 Million USD 1781.551%
West Pharmaceutical Services, Inc. -544.9 Million USD 230.96%